NuCana plc (NCNA)
Automate Your Wheel Strategy on NCNA
With Tiblio's Option Bot, you can configure your own wheel strategy including NCNA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol NCNA
- Rev/Share 0.0
- Book/Share 0.0275
- PB 0.0968
- Debt/Equity 0.0414
- CurrentRatio 1.2504
- ROIC -3.3877
- MktCap 402855.5541
- FreeCF/Share -0.1093
- PFCF -0.0243
- PE -0.0276
- Debt/Assets 0.0149
- DivYield 0
- ROE -3.2025
- Rating B-
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 3
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
Downgrade | NCNA | William Blair | Outperform | Market Perform | -- | -- | Aug. 30, 2024 |
News
Aurion Biotech Appoints Donald Munoz as Chief Financial Officer
Published: February 10, 2025 by: Business Wire
Sentiment: Neutral
SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Aurion Biotech, Inc. (Aurion), whose mission is to restore vision to millions of patients with life-changing regenerative therapies, announced today that Donald Munoz is joining the Company as chief financial officer (CFO), reporting to Greg Kunst, chief executive officer (CEO). “We are delighted to welcome Don to our executive team,” said Greg Kunst, Aurion's CEO. “Don's track record of strategic and operational financial leadership, coupled.
Read More
About NuCana plc (NCNA)
- IPO Date 2017-09-28
- Website https://www.nucana.com
- Industry Biotechnology
- CEO Mr. Hugh Stephen Griffith
- Employees 20